cough-cold-flu
Patient was instructed on Hyperglycemia. The blood sugar can rise to an unsafe level if: Skipping a dose of pills for diabetes, or skipping a dose of insulin Eating too much food. Feeling a lot of stress. Being sick (such as a severe case of the flu) or having an infection, even if not eating a lot of food.
Instructed on the importance of receiving flu and pneumonia immunizations.
The patient was instructed in pericarditis to evade people with colds or flu. The patient was advised that sitting up and inclined forward on a table may relief chest discomfort.
SN instructed patient / caregiver that Actonel is used to treat and prevent bone loss ( osteoporosis ). SN instructed patient of the side effects of Actonel: nausea, diarrhea, constipation and headache. SN instructed patient / caregiver to report to physician of adverse effects: flu - like symptoms ( e.g., fatigue, fever, aches ), weakness, chest or stomach pain, pain when swallowing, leg or ankle swelling, joint pain, bone pain.
SN educated on medication Escitalopram. This medication is used to treat depression in adults and children and teenagers 12 years or older. Escitalopram is also used to treat generalized anxiety disorder (GAD; excessive worry and tension that disrupts daily life for 6 months or longer) in adults. It works by increasing the amount of serotonin, a natural substance in the brain that helps maintain mental balance. Escitalopram may cause side effects such as nausea, diarrhea, constipation, changes in sex drive or ability, drowsiness, increased sweating, dizziness, heartburn, stomach pain, excessive tiredness, dry mouth, decreased appetite, weight loss, flu-like symptoms, runny nose, sneezing. Tell your doctor if any of those symptoms are severe or do not go away.
Instructed in new medication Singulair and in S/E such as headache, dizziness, fatigue, asthenia, fever, nasal congestion, dental pain, dyspepsia, infectious gastroenteritis, abdominal pain, pyuria, cough, rash, trauma, and influenza.
Instructed in new medication Advair diskus to manage asthma. In addition, warned of possible S/E such as sleep disorders, tremor, hypnagogic effects, compressed nerve syndromes, headache, pain, palpitations, pharyngitis, sinusitis, hoarseness (or dysphonia), rhinorrhea, rhinitis, sneezing, nasal irritation, blood in nasal mucosa, keratitis, conjunctivitis, eye redness, viral eye infections, congestion, nausea, vomiting, abdominal pain and discomfort, diarrhea, gastroenteritis, oral discomfort and pain, constipation, oral ulcerations, oral erythema and rashes, oral candidiasis, appendicitis, dental discomfort and pain, unusual taste, muscular pain, arthralgia, articular rheumatism, muscle stiffness, tightness, rigidity, bone and cartilage disorders, upper respiratory tract infection, upper respiratory tract inflammation, lower respiratory tract viral infection, bronchitis, cough, pneumonia, urticaria, flakiness, disorders of sweat and sebum, sweating, hives, viral infections, chest symptoms, fluid retention, bacterial infections, allergic reactions.
Instructed in new medication Protonix to manage esophagitis. In addition, warned of possible S/E such as headache, insomnia, asthenia, dizziness, chest pain, pharyngitis, rhinitis, sinusitis, diarrhea, flatulence, abdominal pain, eructation, constipation, nausea, vomiting, urinary frequency, hyperglycemia, back pain, neck pain, hypertonia, rash, bronchitis, increased cough, etc. The drug can be taken without regard to meal.
Instructed in new medication Bactroban to manage wound care. In addition, warned of possible S/E such as headache, rhinitis, pharyngitis, burning or stinging with intranasal use, taste perversion, upper respiratory tract congestion, cough with intranasal use, burning pruritis, stinging, rash, pain, and erythema with topical use. Instructed to notify prescriber immediately if no improvement occurs in 3 to 5 days or if condition worsens. Advised not to use other nasal products with Bactroban. Warned patient about local adverse reactions related to drug use. Advised not to use cosmetics or other skin products on treated area.
Instructed in new medication Albuterol to prevent or treat bronchospasm in patients with reversible obstructive airway disease. In addition, warned of possible S/E such as tremor, nervousness, dizziness, insomnia, headache, hyperactivity, weakness, CNS stimulation, malaise, tachycardia, palpitations, hypertension, dry and irritated nose and throat (with inhaled form), nasal congestion, epistaxis, hoarseness, heartburn, nausea, vomiting, anorexia, bad taste in mouth, increased appetite, hypokalemia, muscle cramps, bronchospasm, cough, wheezing, dyspnea, bronchitis, increased sputum or hypersensitivity reactions. Warned patient about possibility of paradoxical bronchospasm. If this occurs, discontinue drug immediately. If more than one inhalation is ordered, instructed to wait at least 2 minutes before repeating procedure. Use of an aero chamber may improve drug delivery to the lungs. If steroid inhaler used, advised to use the bronchodilator first and then advised to wait about 5 minutes before using the steroid. This allows the bronchodilator to open the air passages for maximum effectiveness. Advised to remove canister and wash inhaler with warm, soapy water at least once a week.